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The b3 tubulin gene (bTub60D) is a structural gene expressed during mesoderm development from the extended germ band
stage onward. Expression within the individual mesodermal derivatives is guided by different control elements. The
upstream regions allow expression in the dorsal vessel and the somatic mesoderm while enhancers localized in the first
intron guide expression in the visceral mesoderm. Deletion analysis carried out in transgenic flies revealed independent
regulatory elements for the dorsal vessel and the somatic mesoderm. For expression in the somatic mesoderm, a 279-bp
region is absolutely essential. This region contains a binding site for the Drosophila myocyte-specific enhancer binding
factor 2 (D-MEF2), a MADS-box transcription factor known to be essential for mesoderm development. Deletion or
mutation of this D-MEF2 binding site strongly reduces transcription. This pattern is consistent with the strongly reduced
expression of b3 tubulin in D-mef2 mutant embryos. This analysis furthermore reveals that the D-MEF2 binding site acts
in concert with nearby cis regulatory elements. These data show that the upstream control region of the b3 tubulin gene
is an early target of the D-MEF2 transcriptional activator. © 1998 Academic Press
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INTRODUCTION
In the past decade much insight has been gained into the
regulatory cascade establishing the segmented body plan of
Drosophila. In contrast, far less is known of the regulatory
interactions in organ development. For the mesodermal
germ layer, maternally active genes, which determine the
dorsal–ventral axis, have been well studied (for review see
Govind and Steward, 1991; St. Johnston and Nuesslein-
Volhard, 1992). The genes twist and snail, both of which
encode transcription factors, are zygotically active genes
required for ventral furrow formation during gastrulation
(Boulay et al., 1987; Thisse et al., 1988, 1992). After gastru-
lation the mesoderm splits into splanchnopleura and soma-
topleura giving rise to the visceral muscles, the fat body,
and the body wall muscles, as well as the dorsal vessel,
respectively (for review see Bate, 1993). The homeobox-
containing genes tinman and bagpipe are required for the
differentiation of the visceral mesoderm and the dorsal
vessel (Bodmer, 1993; Azpiazu and Frasch, 1993). In the
somatic mesoderm, muscle founder cells are determined
and recruit surrounding myoblasts for fusion to myotubes
(for review see Bate, 1993). During differentiation of the
major mesodermal derivatives, the b3 tubulin isotype is
expressed and allows one to follow mesoderm differentia-
tion (for review on tubulin genes see Fryberg and Goldstein,
1990; for b3 tubulin in muscle development see Buttgereit
et al., 1996).
In vertebrate systems, muscle-specific transcriptional ac-
tivators have been analyzed, such as the basic helix–loop–
helix proteins MyoD, Myogenin, Myf5, and MRF4 (for
review see Emerson, 1993), which have a single homologue
in Drosophila, the protein product of the nautilus gene
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(Michelson et al., 1990; Paterson et al., 1991). Furthermore,
a member of the myocyte-specific enhancer binding factor
(MEF) transcription factor family is expressed predomi-
nantly during skeletal muscle development of vertebrates
(for review see Olson et al., 1995). The MEF2 transcription
factor family, characterized by the MADS box, has been
shown to regulate MyoD-related genes as well as genes
coding for muscle-specific proteins such as muscle creatine
kinase (Gossett et al., 1989; Martin et al., 1993; for recent
reviews see Olson et al., 1995; Firulli and Olson, 1997).
Recently, the MEF2 homologue of Drosophila, D-MEF2,
has been analyzed by cloning of the corresponding gene
(Lilly et al., 1994; Nguyen et al., 1994; Taylor et al., 1995).
The Drosophila mef2 gene is expressed during gastrulation
starting shortly after twist and snail and continuing
through further mesoderm differentiation. Loss-of-function
mutations of D-mef2 greatly reduce differentiation of the
somatic muscles, whereas development of the visceral
muscles and the heart are less severely disturbed (Bour et
al., 1995; Ranganayakulu et al., 1995; Lilly et al., 1995).
As mentioned above, the b3 tubulin gene is expressed
in the splanchnopleura as well as in the somatopleura
and their derivatives (Gasch et al., 1988; Kimble et al.,
1989, 1990; reviewed in Buttgereit et al., 1996). The b3
isotype is essential for viability (Dettmann et al., 1996).
In previous studies, we started the analysis of the regu-
latory cascade driving expression of this mesoderm-
specific tubulin gene by determining cis-regulatory ele-
ments. This identified separate elements guiding
expression in the somatic and visceral derivatives (Gasch
et al., 1989). In addition to this tissue-specific mode of
transcriptional control, the b3 tubulin gene is regulated
in a distinct stage-specific manner. From stage 10 to stage
12, expression in the visceral mesoderm is regulated
along the anterior–posterior axis by an intron-localized
enhancer and homeotic selector genes like Ultrabithorax
(Hinz et al., 1992). After stage 12 of development, an
additional farther 39-located enhancer mediates expres-
sion in the visceral and somatic mesoderm. In the epi-
dermis, transcription of the b3 tubulin gene is repressed
by engrailed (Serrano et al., 1997). In the somatic meso-
derm, expression up to stage 12 of embryogenesis is
regulated by upstream regions of the b3 tubulin gene,
while after stage 12, expression is regulated by an en-
hancer in the 39 part of the large intron (see Fig. 1 and
Hinz et al., 1992). Since the b3 tubulin gene is expressed
shortly after the D-mef2 gene and b3 tubulin isotype is
greatly reduced in D-mef2 mutant embryos (for details
see Fig. 1B), the b3 tubulin gene is a likely target of
D-MEF2. Furthermore, ectopic expression of D-MEF2 in
the epidermis and ventral midline cells activates expres-
sion of b3 tubulin (Lin et al., 1997), which supports the
idea that D-MEF2 is a regulator for b3 tubulin in the
mesoderm or in at least one of its derivatives. As we will
show in this report, D-MEF2 is indeed a regulator of
bTub60D, acting on an enhancer in the upstream region,
while intron-mediated bTub60D transcription is inde-
pendent of D-MEF2. This allows connection of the regu-
latory cascade of transcriptional activators with the ac-
tivation of structural genes in the somatic mesoderm.
MATERIAL AND METHODS
Construction of lacZ Gene Fusions and P-Element-
Mediated Transformation
Deletion mutants. Previously, the clone pTU6.0-Li, containing
6.0 kb upstream sequence, was generated by adding a HindIII linker
to the AvaII site at 1116 (marked with an asterisk in Fig. 1) in the
59 untranslated region of the b3 tubulin gene and using the EcoRI
site at 26.0 kb (Gasch et al., 1989). For the generation of deletion
mutants, the 6.0-kb EcoRI/HindIII fragment was isolated and
subsequently cut with SphI. The resulting 3.3-kb SphI/HindIII
fragment was used to construct pW/b3/lac23.2. Similarly, the
2.4-kb SmaI/HindIII fragment from pTU6.0 Li was used to generate
pW/b3/lac22.3. Deletion mutants pW/b3/lac21423 and pW/b3/
lac21212 were obtained by exonuclease digestion of the SmaI end
of the SmaI/HindIII fragment. Sequence analysis showed that the
exact breakpoints were at 21423 and 21212, respectively.
To construct pW/b3/lac26.0 (id 24.7 to 23.8) and pW/b3/
lac26.0 (id -4.7 to 21423), internal StuI sites were used to first
create different internal deletions by partial digestion and religa-
tion. These deletion mutants were cut with EcoRI and HindIII,
which again allows directed combination with pUClac20 and pW8
(see below and Gasch et al., 1989). For construction pW/b3/lac26.0
FIG. 1. Map of the b3 tubulin gene. The b3 tubulin gene consists of four exons (translated region, black; untranslated parts, stippled) and
three introns (white boxes). The previously determined control region for early expression in the visceral mesoderm is termed vm1, for the
late vm2 (Hinz et al., 1992). The regions for expression in the heart (h) and the early somatic mesoderm (sm1) are determined in this paper,
while expression from stage 12 onward is regulated by sm2 in the somatic muscles (Hinz et al., 1992). The asterisk marks the AvaII site
used to add a HindIII linker. This HindIII site was ligated with the lacZ reporter gene.
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(id 22.3 to 20.23), pTU6.0-Li was digested with BamHI and
overhanging ends were filled followed by digestion with SmaI and
religation to allow recutting by EcoRI and HindIII.
Fusions between the lacZ reporter gene and the b3 tubulin
gene were performed using the pUClac20 plasmid containing
the Escherichia coli lacZ gene including the translation initia-
tion codon combined with the SV40 trailer and appropriate
restriction sites that have been successfully applied previously
(Michiels et al., 1989; Gasch et al., 1989; Hinz et al., 1992). Gene
fusions were cloned between the EcoRI and the HindIII sites of
the Drosophila P-element transformation vector pW8 (Klemenz
et al., 1987).
MEF2-binding site mutants. Between the deletion end points
in pW/b3/lac21144 and pW/b3/lac21423, a MEF2 binding site
consensus motif is localized between 21241 and 21232. To test
the in vivo role of this motif we first isolated from pTU602Li
(Gasch et al., 1989) the StuI/HindIII fragment (21423 to 1116) and
cloned this into pSL1180, which we named pSL1423. With syn-
thetic oligonucleotides containing recognition sites for EcoRI (O3,
59-ACTGAATTCGCTCTTGGTCTTTCAACTTG-39) or StuI (O4,
59-GTCGGCTCGCCTGCTCTCTCCGGATCA-39), we amplified
the b3 sequences from 21420 to 21247 using pSL1423 as template.
After digestion with EcoRI and StuI, this fragment was cloned into
EcoRI- and StuI-opened pSL1180, verified by sequence analysis, and
named pSL173. To create pSL/dMEF1 the 21144 to 1116 fragment
was isolated from pSL 1423 by a SacI site blunt-ended with T4
DNA polymerase and HindIII and then cloned into the HindIII/StuI
sites of pSL173. This clone carries a deletion of 21247 to 21144
including the D-MEF2 binding motif. The EcoRI–HindIII b3 part of
this clone was ligated to a 4.5-kb HindIII/XbaI fragment containing
the lacZ gene from pUClac20 as well as into the XbaI/EcoRI site of
the pW8 Drosophila transformation vector; the resulting construct
was named pw/b3/21423 (D 21144 to 21212).
For the construction of pSL/MEF21144, we first cloned the
oligonucleotides O1 (59-AATTCTCGTCTAAAAATACCACTCT-
GCAGG-39) and O2 (59-GAGGCAGATTTTTATGGTGAGACG-
TCC-39) flanked by EcoRI or StuI into pSL1180. This region
contains the MEF2 binding motif (bold letters). The properties of
the D-MEF2 binding site were tested in conjunction with the
21144 to 1116 and the 21212 to 1116 fragment of PSL1423. These
constructs, pW/b3/lac21144MEF and pW/b3/lac21212MEF, were
inserted into pW8 with the strategy described above.
To introduce point mutations into the D-MEF2 site in the
upstream promoter of the b3 tubulin gene, we used the b3/
lac21423 cloned into the Bluescript plasmid (KS1423). In vitro
mutagenesis was performed with the Transformer Site-Directed
Mutagenesis kit from Clontech. As selection primer, KSdeltaNot
(59-AGTTCAAGAGTGGCCGCCACC-39) was used. As mutagen-
esis primer Mut6XBA (59-GCGGACGAGAGTCCGTCTAGACA-
TACCACTCTGCATCTCGC-39) was designed to introduce two
base changes into the D-MEF2 binding site (CTAGACAT). The
primer was chosen according to Cserjesi and Olson (1991) to
perform an A to C exchange, which is known to abolish MEF2
binding. We furthermore introduced an A to G exchange to create
a XbaI recognition sequence which allowed selection of the mu-
tagenized sequence. The resulting clone, b3/lac21423 Mut1, was
isolated by Asp718 and HindIII digestion and ligated with the
HindIII/XbaI fragment of pUClac20 (Michiels et al., 1989) and the
HindIII/Asp718-opened P-element transformation vector pW8 to
form the mutant construct.
P-element transformations were performed as published previ-
ously (Hinz et al., 1992).
In Vitro Transcription and Translation and Gel
Retardation Assays
The in vitro transcription/translation of D-mef2 and the corre-
sponding gel mobility-shift assays were performed as described by
Lilly et al. (1994).
The sequences of the oligonucleotides used were as follows: b3,
59-TCCGTCTAAAAATACCACTCTGC-39; MCK, 59-GATCGCT-
CTAAAAATAACCCTGTCG-39; and mut 6, 59-GATCGCTCTA-
AACATAACCCTGTCG-39. Complementary oligonucleotides
were synthesized and hybridized to form double-stranded oligonu-
cleotides.
Fly strains. Fly strains used included Oregon R; w1, snw/w1,
snw; and D-mef2 null mutant D-mef22-21/CyO, wgen11-lacZ.
Immunostaining of Embryos and Whole-Mount in
Situ Hybridizations
Embryos were collected, dechorionized, and stained with anti-b3
antibody or b-galactosidase antibodies (monoclonal from Promega)
using the Vectastain Elite kit (Vector Laboratories) essentially as
described previously (Leiss et al., 1988; Hinz et al., 1992). RNA
whole-mount in situ hybridizations were essentially performed
according to Tautz and Pfeiffle (1989). After dehydration, embryos
were embedded in Epon and photographed under Nomarski optics
with a Zeiss Axioskop. Embryonic stages were determined accord-
ing to Campos-Ortega and Hartenstein (1985).
RESULTS
b3 tubulin expression accompanies mesoderm differen-
tiation and the protein is detectable until hatching. b3
tubulin mRNA distribution, however, decreases in a stage-
and tissue-specific manner during embryogenesis, as sum-
marized in Table 1. Previous analysis revealed a complex
arrangement of regulatory elements in the b3 tubulin gene
(see Fig. 1 for a map of the b3 tubulin gene and the
regulatory properties known previously, as well as those
determined in this study).
We previously determined a region between 21144 and
26.0 kb upstream of the b3 tubulin gene as essential for
expression of b3–lacZ gene fusions in the somatopleura and
somatic muscles. The upstream region furthermore allows
expression in the dorsal vessel (Gasch et al., 1989). After germ
band retraction, expression of the b3 tubulin gene in the
somatic and visceral mesoderm is controlled by the 39 part of
the large intron (Hinz et al., 1992). The aim of this work was
to narrow down essential regions for transcriptional activation
as well as to determine the transactivators involved in the b3
tubulin gene regulation by the upstream control region during
the differentiation of the somatic mesoderm. The appearance
of several DNase I-hypersensitive sites in the upstream region
of the b3 tubulin gene was taken as evidence for multiple
cis-regulatory elements (data not shown). Therefore, a number
of deletion mutants were constructed and the expression
pattern was analyzed in transgenic fly lines.
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Expression in the Somatic Muscles and the Dorsal
Vessel Is the Dependent on the Upstream Region
in Connection with the b3 Promoter Region
Our previous analysis showed that 26.0 kb upstream
sequences direct expression of b3-lacZ gene fusions in the
somatic mesoderm between stage 10 and stage 12, while
21144 bp upstream sequences are insufficient to guide
mesodermal expression (Gasch et al., 1989). The upstream
region furthermore directs b3 tubulin gene expression in
cardioblasts and the dorsal vessel after stage 14.
However, these data do not exclude the possibility that
other elements closer to the promoter are essential as well,
though not conferring tissue specificity by themselves. We
first asked whether the upstream sequences of the b3
tubulin gene act independent of position and orientation in
the context of a heterologous promoter. We chose the hsp70
promoter lacking the heat–shock–responsive elements in
the modified Drosophila transformation vector pWHL in
connection with the E. coli lacZ gene (Hinz et al., 1992). We
tested a region from 20.2 to 26.0 kb in connection with the
hsp70 promoter in both orientations with respect to the
transcription initiation site (Table 2). Transgenic Drosoph-
ila lines harboring these gene fusions reveal expression of
lacZ in neither the somatic muscles nor in the dorsal
vessel. Thus, regulator elements localized between 20.2
and 26.0 kb do not act on a heterologous promoter like
classical enhancer elements but require elements in the b3
promoter. Therefore, all further experiments were designed
in connection with the b3 tubulin gene promoter from
1116 up to the breakpoints indicated.
Separate Elements Guide Expression in the Dorsal
Vessel and Somatic Muscles
We performed a deletion analysis of the upstream region to
narrow down the sequences responsible for tissue-specific
expression in somatic muscles and the dorsal vessel. This
series comprises 59 deletions as well as internal deletions (Fig.
2). b3–lacZ fusions carrying deletions from 24.7 to 23.8
(pW/b3/lac26.0 (id 24.7 to 23.8)) or 23.2 kb upstream regions
(pW/b3/lac23.2) retain the complete expression pattern in the
somatic muscles and the dorsal vessel. Expression was ana-
lyzed in the mRNA level with the lacZ gene as a probe as well
as on the protein level using an anti-b-galactosidase antibody.
The expression pattern in transgenic embryos carrying (pW/
b3/lac23.2) is shown in Figs. 3C and 3D. For comparison, an
anti-b3-tubulin staining is shown in Figs. 3A and 3B. The lacZ
mRNA is detectable until stage 13 in the somatic mesoderm,
TABLE 1
Transcriptional Activity of b3 Tubulin during Embryogenesis in Mesodermal Cells and Their Derivatives
Embryo stage
9 10 11 12 13 14 15 16 17 18
Viscerala 2 11 11 11 11 2 2 2 2 2
Somatic 2 11 11 11 11 1 2 2 2 2
Pharynx 2 2 (1) 11 11 11 11 11 11 2
Dorsal vessel 2 2 2 ? ? 11 11 11 11 2
Chordotonal organsa 2 2 2 2 2 2 11 11 11 2
a Expression in the visceral mesoderm and the chordotonal organs is guided by sequences in the intron (Hinz et al., 1992). For details of
transcriptional analysis see Buttgereit et al. (1996). Embryo stages were assigned according to Campos-Ortega and Hartenstein (1985).
TABLE 2
Expression Patterns of b3–lacZ Gene Fusions in Transgenic Flies
to Analyze Elements Guiding Expression in the Dorsal Vessel
and the Somatic Mesoderm during Drosophila Embryogenesis
Construct
Expression
Number
of linesa
Somatic
muscles
Dorsal
vessel
pW/b3/lac26.0 5 1 1
pW/b3/lac23.2 5 1 1
pW/b3/lac22.3 6 1 1
pW/b3/lac26.0
(id 24.7 to 21423)
11 1 2
pW/b3/lac26.0
(id 24.7 to 23.8)
6 1 1
pW/b3/lac26.0
(id 22.3 to 20.23)
10 2 2
pW/b3/lac21423 3 1 2
pW/b3/lac21144 3 2 2
pW/b3/lac21212 2 2 2
pW/b3/lac21423
(D 21247 to 21144)
3 2 2
pW/b3/lac21144MEF 3 2 2
pW/b3/lac21212MEF 2 2 2
pW/b3/lac21423 mut MEF1 2 1/2b 2
a Different lines with the same construct show identical patterns
of expression in mesodermal derivatives. Some of the lines show
additional variable patterns due to chromosomal integration sites.
The influence from chromosomal sites is more abundant in lines
carrying less than 2.3 kb upstream sequences.
b In stage 16 some muscles are stained, presumably due to very
reduced transcription rates but high b-galactosidase stability.
141Gene Regulation in Drosophila Muscle Development
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
while expression in the dorsal vessel and pharyngeal muscles
is present at dorsal closure (Figs. 3G and 3H). Transgenic
embryos carrying 59 deletions to 21423 bp (pW/b3/lac21423)
or internal deletions 24.7 kb to 21423 bp (pW/b3/lac26.0 (id
24.7 to 21423)) show no expression in the dorsal vessel but
maintain expression in the somatic muscles (Figs. 3E and 3F,
Table 1). Thus, independent elements are involved in the
regulation of b3 tubulin in cardioblasts and body wall
muscles. The deletion mutants pW/b3/lac23.2 (Figs. 3C and
3D) and pW/b3/lac22.3 still confer the complete expression
pattern (Table 1). Taking into consideration that deletions to
22.3 (pW/b3/lac22.3) still guide expression in the dorsal vessel
led us to the conclusion that at least one essential cell-type-
specific regulatory element responsible for expression in the
dorsal vessel is located between 21423 bp and 22.3 kb.
Expression in the Somatic Muscles is Dependent on
a 279-bp Element Which Contains a Binding Site
for D-MEF2
The deletion mutant pW/b3/lac21423 is able to guide
expression in all somatic body wall muscles (Figs. 4A and
4B). However, deletion to 21144 (pW/b3/lac21144) abol-
ishes mesoderm-specific transcription completely (Table 2).
Thus, tissue-specific expression in the somatic mesoderm
is dependent on sequences between the deletion endpoints
at 21423 and 21144.
This 279-bp region contains the sequence motif CTA-
AAAATA, a potential D-MEF2 binding site according to the
consensus
CTAAAAATAA
A G
defined in vertebrates (Cserjesi and Olson, 1991). As has
been shown, the Drosophila protein is able to recognize
the same binding site as the vertebrate MEF2 proteins,
and the Drosophila MEF2 protein binds to the MCK-
MEF2 binding site (muscle creatine kinase; Gosset et al.,
1989; Lilly et al., 1994).
To address the role of the potential D-MEF2 binding
motif, we first attempted to show binding of D-MEF2 to
this motif, using gel mobility-shift assays with in vitro-
translated D-MEF2 (Lilly et al., 1994) and 32P-end-labeled
oligonucleotide containing the b3 tubulin MEF2 binding
site. In comparison to the lysate, two prominent com-
plexes were formed (Fig. 5), representing the binding of
MEF2. The basis for the two mobilities of the complex is
unclear, but homodimerization of MEF2 might cause the
higher mobility shift. Homodimer binding to a single
MADS box binding site has been shown for human
SRF-related protein (Pollock and Treisman, 1991). This
MADS box is identical to the D-MEF2 binding site in the
b3 tubulin gene. When unlabeled b3- and MCK-MEF
binding sites in 100-fold excess were used, both oligonu-
cleotides performed complete competition. Using mut 6,
an oligonucleotide with a mutated MEF2 binding site, no
specific competition could be observed (Fig. 5). These
data show that D-MEF2 binds specifically to the MEF
binding site in the b3 tubulin regulatory upstream region
and that the critical C residue of the MCK sequence is
essential for that binding.
Expression of b3 Tubulin Is Strongly Reduced in
D-mef2 Mutants
Mutant embryos lacking the D-mef2 gene are able to
perform ventral furrow formation and form myoblasts;
however, somatic muscles do not develop, and cardiac
and visceral muscles show severe distortions (Lilly et al.,
1995). The b3 tubulin expression in the somatic meso-
derm is greatly reduced in these embryos, while expres-
sion in the dorsal vessel remains (Ranganagakulu et al.,
1995). However, the data published so far show only
embryos shortly before hatching. Therefore, it cannot be
decided whether the observed b3 tubulin expression is
due to the activity of the upstream or the intron-localized
enhancer (Fig. 1). Therefore, we analyzed the b3 tubulin
distribution in D-mef2 mutant embryos from stage 10 of
embryogenesis onward (Fig. 4). The D-mef2 mutant strain
D-mef222-21/CyO, wgen11-lacZ (Bour et al., 1995) was
chosen as a null mutant. This strain contains a balancer
chromosome which is marked with a wingless–lacZ gene
fusion so that homozygous and heterozygous embryos
can be distinguished in double stainings for b3 tubulin
and b-galactosidase. Figure 4A shows b3 tubulin staining
in a stage 13 embryo. Expression of the lacZ reporter is
limited to the visceral and head mesoderm as well as to
precursors of the peripheral nervous system. No signifi-
cant staining of somatic mesodermal derivatives is ob-
served. In embryos at stage 16, staining of the dorsal
vessel and pharynx is observed as well as staining of some
FIG. 2. Constructs for testing the regulatory capacity of the
upstream region of the b3 tubulin gene. Constructs were named
according to the following logic: pW for the transformation vector
pW8, b3 for the b3 tubulin gene from 1116 (hatched) to the
upstream endpoints given in kilobases or in base pairs, respec-
tively. Thin lines represent the upstream regions, while white
boxes represent the lacZ reporter. For internal deletions (id) the
endpoints are given in parentheses. Expression in the somatic
muscles (sm) and dorsal vessel (dv) is indicated.
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FIG. 3. Separate elements regulate expression of the b3 tubulin gene in the dorsal vessel and the somatic muscles. b3 tubulin
is detected with an isotype-specific antibody recognizing the C-terminal 15 amino acids (Leiss et al., 1988). All somatic muscles
(A) as well as cardioblasts (arrow) of the dorsal vessel (B) are stained. (C–F) Embryos stained with anti-b-galactosidase anti-
body: b3–lacZ gene fusions pW/b3/lac23.2 show expression in the somatic muscles (C) as well as in the dorsal vessel (D, arrow).
In the deletion mutant pW/b3/lac26.0 (id 24.7 to 21423) expression in somatiac muscles is retained (E), whereas no expression
is observed in the dorsal vessel (F). RNA whole-mount in situ stainings reveal that transcription in somatic muscles (G) ceases
much earlier than in the dorsal vessel (arrow) and the pharyngeal muscles, as shown for the pW/b3/lac26.0 (id 24.7 to 23.8) as an
example (H).
143Gene Regulation in Drosophila Muscle Development
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
scattered residual cells, many of which probably repre-
sent the peripheral nervous system which is known to
express b3 tubulin (Buttgereit et al., 1996). This reduc-
tion of b3 tubulin expression may depend upon the
D-MEF2 binding site within the b3 tubulin control
region, but it might also be a secondary effect.
The D-MEF2 Binding Site within the b3 Tubulin
Upstream Control Region Regulates the Level of
Transcription in the Somatic Mesoderm
In order to decide whether the D-MEF2 binding motif
indeed has functional relevance for the regulation of the b3
tubulin gene we first constructed deletion mutants. The
potential D-MEF2 binding site is localized between 21241
and 21232. The promoter region from 21144 to 1116 of the
b3 tubulin gene was isolated and ligated with a PCR
fragment corresponding to 21423 to 21247 (pW/b3/
lac21423 (D 21247 to 21144)) to produce an internal
deletion of 103 bases including the D-MEF2 binding site
(see Fig. 6 for constructs). Staining of transgenic embryos
carrying the construct revealed expression of the b3–lacZ
gene fusion neither at the extended germ band stage when
b3 tubulin expression should start nor at any later stage
(Figs. 7C and 7D). Furthermore, we know that deletion
mutants comprising 21212 bp upstream sequences do not
guide expression (Fig. 6, Table 2). Thus, regulatory elements
must be located between 21212 and 21423. As mentioned
above, this region contains the in vitro confirmed binding
site for D-MEF2. To test whether this MEF2 site is relevant
in vivo, we mutagenized it by changing two bases (A to G
and A to C, see Fig. 6) in the context of the pW/b3/
lacZ21423 construct, which drives wildtype expression in
the somatic muscles. This same A to C change is known to
abolish binding of MEF2 in vertebrates (Cserjesi and Olson,
1991) and we showed above that mut6 oligonucleotides
(with this A to C change) fail to compete binding of D-MEF2
to the b3 D-MEF2 binding site (Fig. 4). We established
transgenic Drosophila fly strains carrying this construct
(pW/b3/lacZ21423mutMEF1) and analyzed the expression
pattern in transgenic embryos. No expression was detected
in the mesoderm (Fig. 7E, compare to Fig. 7A); however, this
line shows expression in the ectoderm. Ectodermal expres-
sion might be due to the chromosomal integration site or,
alternatively, the loss of the D-MEF2 binding site might
abolish repression of the b3 tubulin gene in the ectoderm. It
is very unlikely that D-MEF2 is the repressor, as D-MEF2
expression is not detected in the ectoderm. However, an-
other factor with similar binding sites cannot be excluded.
Weak b-galactosidase expression was observed in myotubes
FIG. 4. b3 tubulin gene expression is strongly reduced in D-mef2 null mutants. b3 tubulin distribution is shown in the wildtype situation
(A and C, stained with anti-b3 tubulin antibodies) in comparison to D-mef2 null mutants mef222-21/CyO, wgen11lacZ (Bour et al., 1995)
stained with anti-b-galactosidase and anti-b3-antibodies as depicted in B and D (anti-b-galactosidase has been used to distinguish
heterozygous from homozygous embryos) (see Material and Methods). At stage 13 the mutants show expression only in the visceral
mesoderm (arrow in B) and precursors of the peripheral nervous system (arrowheads in B). In contrast the somatic muscles are not
significantly stained. At stage 16 (D) the mutants show expression of b3 tubulin in the pharyngeal mesoderm (arrowhead) and the dorsal
vessel (arrow) as well as a few scattered cells.
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of stage 16 and 17 embryos after prolonged staining (Fig. 7G
and Table 2). We interpret that this result is due to a severe
reduction of transcription of the lacZ reporter gene as a
consequence of the mutagenized D-MEF2 binding site.
b-Galactosidase has been shown to be stable, and we
assume that accumulation in myotubes results from a very
low transcription level in some precursors. This view is
supported by analyzing embryos at stage 12/13 of develop-
ment, at which weak expression is observed in mesodermal
cells (Fig. 7; compare to Fig. 4A for b3 tubulin expression at
that stage).
We furthermore tested whether the D-MEF2 binding site on
its own is able to guide expression of the b3 tubulin gene in
connection with b3/lac21144. Therefore, we ligated the
D-MEF2 binding site in front of this construct (for details see
Material and Methods). The resulting construct pW/b3/
lac21144 MEF guides no expression in the mesoderm of
transgenic flies (see Fig. 6 and Table 2), indicating that the
D-MEF2 binding site is not able to direct expression on its
own. Another deletion mutant leaves the D-MEF2 binding
site in the native position (pW/b3/lacZ21212 MEF). Also in
transgenic embryos carrying this construct, no expression of
the reporter gene is observed, clearly demonstrating that the
D-MEF2 site is not sufficient to guide b3 tubulin expression
mediated by the upstream enhancer but that it acts in com-
bination with elements between 21247 and 21423.
The data presented in this report clearly show that while
it is essential for the expression of the b3 tubulin gene in
the somatic mesoderm, the D-MEF2 transcription factor on
its own is not able to exert this function but requires other
cis-acting elements in its vicinity.
DISCUSSION
We are interested in determining regulatory cascades
during mesoderm development of Drosophila. One of our
FIG. 5. Binding of D-MEF2 to b3 tubulin MEF2 site. An oligonu-
cleotide probe encompassing the putative MEF2 site from the b3
tubulin gene was used in gel mobility-shift assays with D-MEF2
translated in vitro. Unprogrammed lysate was used in the lane on
the far left. Specificity of binding was demonstrated by competition
using a 100-fold excess of unlabeled oligonucleotides corresponding
to the b3 tubulin MEF2 site; a mutant MEF2 site called mutant 6,
which does not bind MEF2; and the MCK MEF2 site. The bracket
to the left indicates the position of the MEF2–DNA complex. The
complex observed with lysate lacking D-MEF represents the bind-
ing of a nonspecific protein.
FIG. 6. Constructs to analyze the functional relevance of the
D-MEF2 binding site in the b3 tubulin enhancer. The pW/b3/
lac21423 constructs are taken as a reference for expression in the
somatic mesoderm. The D-MEF2 binding site is marked as a black
box. Below, three deletion constructs which delete the D-MEF2
binding site and different adjacent sequences are shown. Two
further constructs test the position dependence and influence of
flanking sequences in connection with the D-MEF2 binding site
(pW/b3/lac21144MEF and pW/b3/lac21212MEF). The last con-
struct contains a mutated D-MEF2 binding site (pW/b3/lac21423
mut MEF1; see Material and Methods for details).
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approaches is the characterization of regulatory elements
and transactivators of the b3 tubulin gene.
Shortly after gastrulation the mesoderm splits into soma-
topleura and splanchnopleura and b3 tubulin starts to be
expressed. During differentiation, the somatopleura and the
splanchnopleura continue to express b3 tubulin. This ex-
pression accompanies the fusion process leading to forma-
tion of somatic muscles and dorsal vessel and differentia-
tion of the visceral muscles, while the embryonic gonadal
mesoderm and the fat body do not express this tubulin
isotype (for review see Buttgereit et al., 1996). The regula-
tory capacities of the b3 tubulin gene reflect the complex
mesodermal differentiation pathway in that many separate
regulatory units are responsible for tissue-specific expres-
sion. We previously showed that expression in the visceral
mesoderm is guided by enhancers in the large intron and by
trans-acting homeotic gene products in combination with
tissue-specific factors (Hinz et al., 1992). Expression of b3
tubulin in the somatic muscles, the dorsal vessel, and the
pharyngeal muscles is dependent on sequences upstream of
21144 bp in combination with promoter elements. The
situation is complicated by stage-specific enhancers in the
39 part of the large intron which guide expression in somatic
and visceral muscles after germ band retraction (Hinz et al.,
1992). Thus, the b3 tubulin gene is under a very complex,
cell-type specific control (see Fig. 1 for a summary). In
addition to the mesoderm activating elements, recently
engrailed was shown to repress b3 expression in the ecto-
derm (Serrano et al., 1997).
D-MEF2 is expressed in all mesodermal precursor cells
during gastrulation and remains active in the somatic
muscles and visceral muscles, while no expression is
observed in the fat body (Lilly et al., 1995). Thus, D-MEF2
precedes and parallels the b3 tubulin expression during
early developmental stages. These data led us to investi-
gate whether D-MEF2 is a transactivator of b3 tubulin.
FIG. 7. Biological role of the D-MEF2 binding site in the b3
tubulin gene. Embryos were stained with anti-b-galactosidase
antibody. (A, C, and E) Expression pattern at the extended germ
band stage. (B, D, and G) Expression at stage 16 of embryonic
development. (F) Expression at late stage 12. pW/b3/lac21423-
containing embryos show expression in the mesoderm (A) as well
as in the somatic muscles (B). As can be judged by microscopic
analysis, all myotubes reveal expression of the reporter gene in
transgenic embryos carrying the pW/b3/lac21423 construct. How-
ever, we have to consider that muscle fibers are syncytial cells
originating from fusions of a number of myoblasts. b-Galactosidase
expression pattern revealed in early stages (A) can be seen in many
myoblasts, which led us to assume that the majority of myoblasts
express the lacZ gene. (C and D) Transgenic embryos containing
pW/b3/D21144 to 21212, having the D-MEF2 binding site deleted,
do not express the gene fusion. (E, F, and G) Transgenic embryos
containing pW/b3/lac21423mutMEF1 with a mutagenized binding
site. Mesodermal expression is lost at the extended germ band
stage; however, expression is observed in the epidermis (E, arrow-
heads). In stage 16, a low level of reporter gene expression in
muscles is visible (compare G to B). In late stage 12 (F) a low
expression level is observed in some mesodermal cells (arrow-
heads), presumably causing late staining of myotubes (G).
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For the somatic muscles we could show that a region
between 21144 and 21423 is essential. This region
contains a D-MEF2 binding site. Mutagenesis of this
D-MEF2 binding site strongly reduces transcription of
b3–lacZ gene fusions which shows that full-level expres-
sion is dependent on the MADS-box transcription factor
D-MEF2. Also, in the vertebrate muscle creatine kinase
(MCK) enhancer, where MEF2 binding sites were first
identified, these MEF2 binding sites are required for full
enhancer activity (Gossett et al., 1989). MEF2 factors can
homo- and heterodimerize (for review see Olson et al.,
1995). Our investigations show that the b3 D-MEF2
binding site is an essential cis-regulatory element in the
somatic mesoderm and that aside from this element
other elements are required for transcription of the b3
tubulin gene. This analysis furthermore reveals that the
D-MEF2 binding site acts in concert with nearby cis-
regulatory elements. Mutants of D-MEF2 are character-
ized by the absence of somatic muscles and by a bloated
midgut, although the dorsal vessel is formed (Lilly et al.,
1995). b3 tubulin is expressed in the visceral mesoderm
in D-MEF2 mutants making it very unlikely that
D-MEF2 is a regulator of the bTub60D gene in the
visceral mesoderm. Furthermore, the sequence of the
enhancer that guides expression in the visceral meso-
derm gives no evidence for involvement of D-MEF2 in
this process. At first glance, this seems to be a discrep-
ancy, but the highly complex arrangement of regulatory
sequences in the bTub60D gene has to be considered (see
Fig. 1 for a summary). Early expression of bTub60D gene
is regulated by the upstream enhancer, whereas the
expression after stage 12 in the somatic mesoderm is
regulated by an enhancer in the intron which is devoid of
potential binding sites for D-MEF2 (Hinz et al., 1992).
Data of Bour et al. (1995) and Ranganayakulu et al. (1995)
show some residual expression of the b3 tubulin isotype in
unfused myoblasts of D-mef2 null mutants after dorsal
closure. The b3 staining in D-MEF2 mutants is probably
due to the redundancy of b3 enhancers localized in the
intron, which activate the b3 tubulin gene (bTub60D) from
stage 13 onward (Hinz et al., 1992). Recently, Lin et al.
(1997) analyzed the consequence of ectopic expression of
D-MEF2 which leads to bTub60D activation in the epider-
mis at stage 12, which probably is due to the D-MEF2
binding site described here. Activation in the epidermis
argues for cofactors which are present in the epidermis as
well as in the mesoderm.
In addition to regulating b3 tubulin expression,
D-MEF2 has been shown to activate other target genes in
the mesoderm. For example, the tropomyosin gene is a
typical structural gene expressed late in mature muscles.
Recently, Lin et al. (1996) showed that D-MEF2 is one of
the regulators of Drosophila tropomyosin gene (Tm1)
expression in somatic muscles. The Tm1 gene contains
two muscle-specific enhancers in the first intron of the
gene. Both enhancers contain a MEF2 binding site, mu-
tation of which reduces expression significantly (Lin et
al., 1996). As in the case of the b3 tubulin gene, tropo-
myosin expression is reduced but not eliminated in
D-mef2 mutants. For the b3 tubulin gene, we know that
a D-MEF2-independent enhancer in the intron is respon-
sible for expression in myotubes, while in earlier stages
MEF2 is an essential but not sufficient component for
high level of expression in vivo. Also in D-mef2 mutants,
b3 tubulin is expressed in the dorsal vessel. We find that
the region from 21423 bp to 22.3 kb is essential for
expression in the dorsal vessel. This essential enhancer
does not contain a D-MEF2 consensus sequence, and thus
probably is regulated by other transactivators. From our
previous analysis of the b3 visceral enhancer in trans-
genic flies (Hinz et al., 1992) and the sequence analysis,
we have no evidence for a role of D-MEF2 in the regula-
tion of the b3 tubulin gene in the visceral mesoderm.
Interestingly, expression of tropomyosin in the heart and
visceral mesoderm is also independent of D-MEF2 (Lin et
al., 1996). There is no myosin heavy chain expression in
the muscles or in the dorsal vessel of D-mef2 mutants,
showing that individual genes coding for structural
muscle proteins underlie different control mechanisms
in Drosophila.
MEF2 is expressed in many mesodermal cell types during
vertebrate and Drosophila embryogenesis. In vertebrates,
MEF2 factors regulate a number of genes expressed in
different mesodermal derivatives (for review see Olson et
al., 1995). Thus, MEF2 activation of target genes requires
cooperation with other regulatory factors in a cell-type-
specific manner. The regulation of the Drosophila tropo-
myosin gene (Lin et al., 1996) and b3 tubulin gene shows
that the situation is the same in Drosophila.
In D-mef2 mutants, muscle precursor cells are deter-
mined (Bour et al., 1995; Ranganayakulu et al., 1995),
suggesting that D-MEF2 regulates genes essential for myo-
blast fusion and muscle components, but not for precursor
determination. Both D-MEF2 expression and b3 tubulin
expression precede muscle lineage determination, and we
show here that the b3 tubulin gene is an early target of the
D-MEF2 transcriptional activator during early phases of
differentiation of the somatic mesoderm. Our evidence
indicates that the regulatory properties of the MADS-box
transcription factor D-MEF2 in the activation of muscle-
specifically expressed genes are conserved between Dro-
sophila and vertebrates.
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